•  

Dos and Don'ts in Health Technology Assessments

A session at Dos and Don'ts in Health Technology Assessments

Understand What is HTA - What it is Not
- Definitions
- Different types of HTA and the wide variety across countries
- 15 Key Principles

Thresholds Used by HTA Bodies in ICER-based Decision Making
- Recap of basic health economic principles (e.g. QALY, ICER ...)
- The variety of thresholds used across HTA bodies and how they influence decision making

Selecting from the Wide Range of Criteria
- Exploring the assessment criteria in HTA and their relative weight
- Using Multi-Criteria Decision Analysis (MCDA) to determine weights and influence decision making
- Trading off between criteria

Issues & Solutions for Optimising the Quality of the Evidence
- 'EMA' trials versus 'HTA' trials
- Reconciling the need for RRR vs. ARR data
- When to do ITT vs. when Per Protocol
- Compliance and Persistence are not synonyms!
- Extrapolating short term clinical data and surrogate endpoints
- Dealing with indirect effects

Effectively Working with HTA Processes Across the EU
- The optimal HTA process: does it exist?
- Learn from differences between countries
- The benefits and risks of international cooperation
- 'Adaptive' HTA and contracts based on outcomes guarantees

Summary of Dos and Don'ts and final discussion

Closing

Price:
Standard: EUR1.470

Speakers: Prof. Dr. Lieven Annemans

Category: Conferences | Science, Health and Medicine | Pharmaceuticals | Regulatory Affairs

Sign in to add slides, notes or videos to this session

Tell your friends!

When

Date Tue 9th June 2015

Short URL

lanyrd.com/sdphzg

Official event site

atnd.it/25061-0

View the schedule

Share

See something wrong?

Report an issue with this session